Birth Control Patch Study

NCT00984789 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

393

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016)
DRUG: Norelgestromin/Ethinylestradiol (EVRA)

Sponsor

Bayer

Collaborators

[object Object]